Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $60.31 | 4 | 51.1% |
| Education | $57.65 | 3 | 48.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $31.80 | 1 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $18.44 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $15.83 | 1 | $0 (2022) |
| Acrotech Biopharma LLC | $13.93 | 1 | $0 (2021) |
| Incyte Corporation | $13.28 | 1 | $0 (2020) |
| Kite Pharma, Inc. | $12.76 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $60.39 | 3 | PFIZER INC. ($31.80) |
| 2021 | $44.29 | 3 | BOSTON SCIENTIFIC CORPORATION ($18.44) |
| 2020 | $13.28 | 1 | Incyte Corporation ($13.28) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: Oncology | ||||||
| 07/26/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $12.76 | General |
| 05/26/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 09/08/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 08/06/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 596 | 1,199 | $306,691 | $99,344 |
| 2022 | 8 | 639 | 1,307 | $323,433 | $108,564 |
| 2021 | 8 | 673 | 1,359 | $433,962 | $115,152 |
| 2020 | 8 | 737 | 1,562 | $492,946 | $112,466 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 262 | 619 | $135,720 | $42,248 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 139 | 317 | $97,252 | $32,817 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 69 | 69 | $29,607 | $9,115 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 46 | $17,850 | $5,977 | 33.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 73 | $12,634 | $4,325 | 34.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 37 | $9,251 | $3,298 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 17 | $2,432 | $788.80 | 32.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $1,945 | $775.95 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 275 | 694 | $149,210 | $48,187 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 140 | 300 | $90,000 | $32,334 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 75 | 75 | $31,500 | $9,696 | 30.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 56 | $21,280 | $8,344 | 39.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 101 | $17,170 | $5,395 | 31.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 41 | $10,045 | $3,176 | 31.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 28 | $2,548 | $821.14 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 12 | $1,680 | $611.61 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 276 | 712 | $198,648 | $50,741 | 25.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 152 | 316 | $118,500 | $33,185 | 28.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 93 | 93 | $50,220 | $12,715 | 25.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 59 | $31,978 | $8,970 | 28.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 99 | $19,602 | $5,403 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 27 | $7,641 | $2,119 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 21 | $3,885 | $1,083 | 27.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 32 | $3,488 | $935.68 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 309 | 891 | $248,589 | $51,316 | 20.6% |
About Dr. David Lee, MD
Dr. David Lee, MD is a Hematology healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639171580.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lee, MD has received a total of $117.96 in payments from pharmaceutical and medical device companies, with $60.39 received in 2022. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($60.31).
As a Medicare-enrolled provider, Lee has provided services to 2,645 Medicare beneficiaries, totaling 5,427 services with total Medicare billing of $435,527. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Olathe, KS
- Active Since 08/11/2005
- Last Updated 12/07/2018
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1639171580
Products in Payments
- IBRANCE (Drug) $31.80
- WATCHMAN (Device) $18.44
- OPDIVO (Biological) $15.83
- BELEODAQ (Drug) $13.93
- JAKAFI (Drug) $13.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.